L&K Biomed Ltd. (KOSDAQ: 156100)

L&K Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	133,177	202,956	107,379	143,972	505,923	73,024
Market Cap Growth	-20.45%	89.01%	-25.42%	-71.54%	592.81%	-2.93%
Enterprise Value	130,239	200,512	115,624	150,234	520,503	108,870
Last Close Price	6680.00	10180.00	7212.36	9679.51	35296.46	6311.94
Forward PE	-	25.02	25.02	25.02	25.02	25.02
PS Ratio	4.02	6.79	5.43	9.37	26.14	2.75
PB Ratio	3.51	6.64	9.98	5.81	14.81	2.05
P/TBV Ratio	3.78	5.87	9.29	6.19	16.57	2.71
P/OCF Ratio	-	-	-	-	-	117133.09
EV/Sales Ratio	3.92	6.70	5.85	9.77	26.89	4.10
EV/EBITDA Ratio	26.96	46.12	-	-	-	-
EV/EBIT Ratio	63.61	98.58	-	-	-	-
Debt / Equity Ratio	0.68	0.44	2.34	0.91	0.59	0.73
Debt / EBITDA Ratio	4.34	3.11	-	-	-	-
Asset Turnover	0.47	0.52	0.35	0.26	0.30	0.32
Inventory Turnover	0.23	0.24	0.33	0.48	0.31	0.72
Quick Ratio	0.85	1.04	0.50	1.69	0.58	0.74
Current Ratio	1.53	1.95	0.95	3.01	1.63	1.42
Return on Equity (ROE)	-14.74%	-25.34%	-91.33%	-46.30%	-30.56%	-26.41%
Return on Assets (ROA)	2.07%	2.20%	-14.22%	-16.15%	-3.69%	-7.09%
Return on Capital (ROIC)	2.70%	3.18%	-19.14%	-18.84%	-4.16%	-8.37%
Earnings Yield	-1.12%	-0.92%	-12.69%	-6.72%	-2.12%	-14.74%
FCF Yield	-8.98%	-1.68%	-6.22%	-7.29%	-0.54%	-0.79%
Buyback Yield / Dilution	-37.35%	-21.04%	-0.07%	-12.57%	-14.15%	-5.11%
Total Shareholder Return	-37.35%	-21.04%	-0.07%	-12.57%	-14.15%	-5.11%

Source: S&P Capital IQ. Standard template. Financial Sources.